CareSource awarded Nevada Medicaid Managed Care contract
Erhardt Preitauer
HENDERSON, Nev., April 15, 2025 (GLOBE NEWSWIRE) -- The Nevada Department of Health and Human Services Division of Health Care Financing and Policy has awarded CareSource, a nationally-recognized, nonprofit managed care organization, a contract for the Nevada Medicaid Managed Care Program to begin January 1, 2026. As the only nonprofit selected, CareSource will help expand managed care into Nevada's rural counties, as well as its two most populous counties, Clark and Washoe, home to the Las Vegas metropolitan area and the City of Reno.
"At CareSource, we know that too many Nevadans face barriers to accessing quality health care," said Erhardt Preitauer, president and CEO of CareSource. "Our passion has always been to remove those barriers and ensure that every individual gets the care they deserve. As a proud University of Nevada, Reno graduate, I'm especially excited to bring our personalized approach to managed care to the Silver State. Together, we can turn challenges into opportunities and build a stronger, healthier future for members across the state.'
CareSource goes beyond providing essential health services, prioritizing whole-person care through innovative programs that address social determinants of health. As a nonprofit, CareSource reinvests in initiatives that support members' broader needs, from housing and nutrition to employment. Through its CareSource Life Services® program, the company partners with community-based organizations to connect members with critical resources, ensuring they receive the support needed to thrive beyond health care.
"CareSource Nevada is proud to serve the people of Nevada with a commitment to whole-person care and improving health outcomes," said Jayme Puu, CEO of CareSource Nevada. "We're excited to partner with state leadership, hire local talent and contribute to economic growth as we work to meet the unique health care needs of the state."
To date, CareSource has contributed $300,000 to Communities In Schools (CIS), including $50,000 to support essential wraparound services through CIS of Nevada. Additionally, the CareSource Foundation awarded $300,000 to the Nevada Primary Care Association to help rural providers improve health care access and outcomes across the state.
Nevada's Medicaid open enrollment runs October 1 to October 31, with services beginning January 1, 2026. To learn more about CareSource Nevada, please visit https://www.caresource.com/nevada/.
###
About CareSource Nevada CareSource Nevada is a nonprofit managed care organization that provides access to high quality care to Nevada Medicaid and Nevada Check-Up-eligible residents of the Silver State. CareSource Nevada transforms health care for Nevadans throughout the state through innovative programs that address the social determinants of health, prevention and access to care. Through a robust provider network and partnerships with community-based organizations in every region of Nevada, CareSource Nevada delivers care with heart.
Learn more at CareSource.com/Nevada or follow us at Facebook.com/CareSourceNV
About CareSource CareSource is a nonprofit, nationally recognized managed care organization with over 2 million members. CareSource administers one of the largest Medicaid managed care plans in the U.S. The organization offers health insurance, including Medicaid, Health Insurance Marketplace and Medicare products. As a mission-driven organization, CareSource is transforming health care with innovative programs that address the social determinants of health, prevention and access to care.
For more information, visit us at www.caresource.com, or follow us on X, formerly known as Twitter, LinkedIn or Facebook.
Attachments
Jayme Puu
Erhardt Preitauer
CONTACT: Hannah Krafka CareSource 937-531-3635 Hannah.Krafka@CareSource.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
an hour ago
- Wall Street Journal
Medicaid Is Huge. Here's Why, and What Trump's Cutting
Medicaid began as a welfare program, but 60 years later it covers one in five Americans. WSJ explains how it got so big, and how the 'Big Beautiful Bill' will change it. /Bloomberg
Business Upturn
4 hours ago
- Business Upturn
ABOG Announces 2025 Board and Division Appointments
Dallas, Texas, July 16, 2025 (GLOBE NEWSWIRE) — The American Board of Obstetrics and Gynecology (ABOG) is proud to announce the appointment of two new members to its Board of Directors, one new Public Member, two new Division Chairs, and four new Division Members, effective July 1, 2025. One of the two members at large was selected to represent the voice of the community and rural practice. These appointments reflect ABOG's continued commitment to leadership, inclusivity, and public engagement across both the medical and broader community landscapes. Board Appointments Randal Robinson, MD, MBA – At-Large Board Member Randal Robinson, MD, MBA, has been appointed as an At-Large Member of the Board. This board position was recruited from individuals who represented community and rural experience perspectives, ensuring representation from physicians who practice outside of academic medical centers, research institutions, and teaching hospitals. Robinson brings a wealth of experience and a deep understanding of the unique challenges faced by these practitioners, making him exceptionally well-suited to serve in this important position. His experience in rural care began early in his career while serving in the U.S. Army, practicing full-scope OB-GYN in Fairbanks, Alaska. There, he provided comprehensive care to military families, including traveling by helicopter to reach remote patients. 'Practicing in Fairbanks gave me a unique understanding of the challenges faced by OB-GYNs in rural settings,' Robinson shared. 'It shaped my perspective and deepened my appreciation for the physicians who serve in these communities every day.' Robinson ultimately subspecialized in Reproductive Endocrinology and Infertility and has been an ABOG Reproductive Endocrinology and Infertility (REI) Certifying Examiner since 2015 and previously served as an OB-GYN Certifying Examiner from 2007 to 2022. He is currently Chair of the Department of Obstetrics and Gynecology at UT Health San Antonio and previously served as an active-duty Colonel in the U.S. Army Medical Corps, where he served for 26 years. Through his years of service, he practiced broadly across the full scope of the specialty to support his faculty colleagues. His leadership also includes service on the Accreditation Council for Graduate Medical Education (ACGME) Review Committee and as Vice Chair Retired – Armed Forces District of ACOG. Matthew Barber, MD, MHS – At-Large Board Member Matthew Barber, MD, MHS, has been appointed as an At-Large Member of the Board, marking his return after previously serving from 2021 to 2024 as a Subspecialty Division Chair and a Board Member. His reappointment brings valuable continuity and deep institutional knowledge to the organization. Barber has also served as an OB-GYN Certifying Examiner since 2013 and a Urogynecology and Reconstructive Pelvic Surgery (URPS) Certifying Examiner since 2016. He is also a member of ABOG's Certifying Exam Development Committee. Barber currently serves as the President of the Duke Health Integrated Practice and Vice Dean for Clinical Affairs at the Duke School of Medicine and holds the W. Allen Addison Distinguished Professorship in the Department of Obstetrics and Gynecology, where he also recently served as Department Chair. 'It's a privilege to return to the ABOG Board and continue contributing to an organization so deeply committed to excellence in women's health,' said Barber. 'I've seen firsthand the impact of ABOG's work, and I'm excited to once again collaborate with such a dedicated group of leaders to advance our mission and support the next generation of OB-GYNs.' Holly Peña – Public Member Holly Peña joins the Board of Directors as its newest Public Member. As Public Member, Peña serves as a bridge between the medical community and the patients it serves, bringing forward the perspectives of individuals, families, and communities impacted by OB-GYN care. Her perspective helps ensure that the Board's work remains grounded in the real-world experiences, values, and needs of the broader public. As co-founder and CEO of Peña Search Consulting, an executive search firm serving the nonprofit sector, Peña has helped organizations identify and engage transformative leaders for over fifteen years. This and her prior background in international law and legal recruitment, combined with her global experience and bicultural perspective, gives her a distinctive understanding of equity, effective communication, and meaningful community engagement. 'I'm honored to serve as a Public Member on the ABOG Board,' said Peña. 'It's a privilege to represent the voices of patients and communities, and to contribute to the advancement of women's health through thoughtful, inclusive leadership.' Division Chair Appointments Stephanie V. Blank, MD – Subspecialty Division Chair, Chair of Gynecologic Oncology (GO) Division Stephanie V. Blank, MD, has been appointed Chair of the Gynecologic Oncology Division and will also serve as the Subspecialty Division Chair of the Board of Directors. Blank has been an OB-GYN Examiner since 2000, a Gynecologic Oncology Examiner since 2015 and has served on the ABOG Gynecologic Oncology Division since 2019. She currently serves as Director of Gynecologic Oncology for the Mount Sinai Health System and is a Professor in the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai. Additionally, she is co-Director of the Center of Excellence for Gynecologic Cancer at the Tisch Cancer Center. 'I'm grateful for the opportunity to help shape the future of gynecologic oncology by supporting the highest standards of care and clinical excellence for our patients,' Blank said. Clarisa Gracia, MD – Chair of Reproductive Endocrinology and Infertility (REI) Division Clarisa Gracia, MD, MSCE, has been appointed Chair of the REI Division. Dr. Gracia has served as an REI Certifying Examiner since 2014 and served on the REI Subspecialty Division since 2020. Dr. Gracia is Chief of the REI Division at the University of Pennsylvania Perelman School of Medicine and holds the Nancy and Richard Wolfson Professorship of Obstetrics and Gynecology at Penn. 'I'm honored to have the opportunity to contribute to ABOG's mission to advance knowledge, clinical practice, and professionalism in the subspecialty of REI,' Gracia said. 'I look forward to working alongside dedicated leaders who share a passion for improving women's health and shaping the future of the next generation.' Division Member Appointments Gynecologic Oncology (GO) Michael McHale, MD Professor, Department of Obstetrics, Gynecology, and Reproductive Sciences Chief, Division of Gynecologic Oncology Services UC San Diego School of Medicine Maternal-Fetal Medicine (MFM) Kimberly Fortner, MD Professor and Vice Chair, Department of Obstetrics and Gynecology Director, Division of Maternal-Fetal Medicine University of Tennessee College of Medicine-Knoxville Vice President, Women and Infants Center of Excellence, University of Tennessee Medical Center Reproductive Endocrinology and Infertility (REI) Belinda Yauger, MD Professor, Department of Obstetrics & Gynecology Chief, Division of Reproductive Endocrinology and Infertility UT Health San Antonio Urogynecology and Reconstructive Pelvic Surgery (URPS) Gena Dunivan, MD Professor, Department of Obstetrics and Gynecology Director, Division of Urogynecology and Reconstructive Pelvic Surgery University of Alabama at Birmingham School of Medicine Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
4 hours ago
- Business Upturn
VLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine Mandate
Multiple Tobacco Brands Partnering with 22nd Century to Expand Availability and Awareness of VLN Based Reduced Nicotine Content Products Manufactured in the USA, VLN Products from 22nd Century Provide Clinically Proven Solution to Reduce the Rate and Harms of Smoking MOCKSVILLE, N.C., July 16, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction is creating a new pathway to reducing the rate of smoking and related health harms through increasing adoption of its VLN® reduced nicotine content cigarette products by additional brands. Our products incorporate proprietary and patented tobacco having 95% less nicotine than tobacco used in highly addictive conventional cigarettes. Decades of peer reviewed studies have shown that the level of nicotine content in 22nd Century's products can reduce both the rate of smoking and the health harms of smoking. The recently announced partner VLN® initiatives, such as Smoker Friendly VLN®, Pinnacle VLN®, reflect a growing commitment by tobacco brands to accelerate compliance with the U.S. Food and Drug Administration's proposed new Tobacco Product Standard for Nicotine Yield of Cigarettes and Certain Other Combusted Tobacco Products, which is intended to curb the harms of smoking. 'The FDA recognizes that nicotine is a highly addictive substance and that to achieve true tobacco harm reduction, nicotine consumption must be addressed. The FDA's new product standard proposed in January is one of many factors that are driving early commercial interest in our VLN reduced nicotine content tobacco products. We are excited to see our customer's brands adding VLN cigarettes to their lineup. This will enhance market availability of VLN cigarettes and offer customers a Tobacco Harm Reduction product that will give the smoker a choice to control their nicotine consumption,' said Larry Firestone, Chief Executive Officer of 22nd Century Group. 'These commercial launches and our readiness once we receive state approval to scale availability to all 50 states for the entire U.S. cigarette market continues to demonstrate that there need not be any commercial barriers to adopting this FDA policy, which could be the most impactful health decision in a generation.' Formally announced in January 2025, the proposed standard sets a maximum nicotine content of 0.7 mg of nicotine per gram of tobacco in cigarettes and certain other combusted tobacco products, taking effect two years from final approval. VLN® based products from 22nd Century are the only combustible cigarette products authorized by the FDA to meet the standard, at an average of 0.5 mg per gram, and the only product that offers consumers a choice about their nicotine consumption. On implementation of the FDA proposal, people who are addicted and wish to alter their dependency or even quit could have the ability to do so more easily, significantly reducing the morbidity and mortality caused by smoking. Based on FDA's population health model, by the year 2100, in the United States, approximately 48 million youth and young adults who would have otherwise initiated smoking would not start as a result of the proposed product standard. 22nd Century is monitoring comment submissions under the proposed rule and intends to make its own submission before the comment period closes. This activity follows the 2018 rule making process, which ultimately incorporated many of the suggestions, independent clinical research studies and feasibility data from 22nd Century's comment letter at that time, including: A proposed standard of not more than 0.7mg/g of nicotine content, based on 22nd Century's recommendation of an average of 0.5mg/g, The fact that our patented low nicotine content tobacco leaf contained in our VLN Products that already meets the standard can be readily sourced in enough quantity to meet demand for reduced nicotine content cigarette products, and The fact the reduced nicotine content tobacco is an effective way to reduce the rate and harms of smoking, as documented by dozens of peer reviewed and published independent clinical studies using research cigarettes manufactured by 22nd Century The FDA's January 15, 2025 press release announcing the rule includes the following statement from the former FDA Commissioner Robert M. Califf, M.D.: 'Today's proposal envisions a future where it would be less likely for young people to use cigarettes and more individuals who currently smoke could quit or switch to less harmful products. This action, if finalized, could save many lives and dramatically reduce the burden of severe illness and disability, while also saving huge amounts of money. I hope we can all agree that significantly reducing the leading cause of preventable death and disease in the U.S. is an admirable goal we should all work toward.' About 22nd Century Group, Inc. 22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption. We created our flagship product, the VLN® cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them take control of their nicotine consumption . VLN® cigarettes have 95% less nicotine than the traditional cigarette and have been proven to allow consumers to greatly reduce their nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether. Our proprietary reduced nicotine tobacco blends are made possible by comprehensive and patented technologies and tobacco plants that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets. VLN® is a registered trademark of 22nd Century Limited LLC. Learn more at on X (formerly Twitter), on LinkedIn, and on YouTube. Learn more about VLN® at Cautionary Note Regarding Forward-Looking Statements Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as 'anticipate,' 'believe,' 'consider,' 'continue,' 'could,' 'estimate,' 'expect,' 'explore,' 'foresee,' 'goal,' 'guidance,' 'intend,' 'likely,' 'may,' 'plan,' 'potential,' 'predict,' 'preliminary,' 'probable,' 'project,' 'promising,' 'seek,' 'should,' 'will,' 'would,' and similar expressions. Forward-looking statements include, but are not limited to, statements regarding (i) our cost reduction initiatives, (ii) our expectations regarding regulatory enforcement, including our ability to receive an exemption from new regulations, (iii) our financial and operating performance and (iv) our expectations for our business interruption insurance claim. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in 'Risk Factors' in the Company's Annual Report on Form 10-K filed on March 20, 2025, and in the Company's Quarterly Reports filed on May 13, 2025. All information provided in this release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law. Investor Relations & Media ContactMatt KrepsInvestor Relations22nd Century Group [email protected] 214-597-8200
